How do we MANAGE a baby withdrawing from a drug? How LONG to observe? What symptoms should we be looking for? What non-pharmacological treatment is recommended? What about BREAST-FEEDING? When do we give meds and WHAT MEDS? --------------------------------------------------------------------- Do you want extra Tala Talks education? A neonatal tip a week? Access to LIVE videos? Behind the scene members-only videos? Worksheets of the videos? Do you want to decide which videos we should be publishing next? If so- join our new (low-priced!) membership community! Join here: https://www.youtube.com/channel/UCxv2qGB7HR5lR2D7IdoUAJA/join Help us guide the future of this channel and get involved in our community!
For PDF summaries of the videos, links to relevant articles (+ 50 free Multiple Choice Questions/ Answers and explanations!!), AND a bunch of other stuff, subscribe to our Neonatal Nuggets Newsletter here: https://talatalksnicu.substack.com/subscribe ---------------------------------------------------------------------- Please be sure to give us a like, comment about future topics, and subscribe to this channel to stay up to date on all things NICU! Also, click the notification bell after you subscribe to gain your weekly NICU knowledge as soon as it's loaded! --------------------------------------------------------------------- Dr. Tala is a board-certified neonatologist and has worked in busy level III and IV units for the past 15 years. She has won multiple teaching awards throughout her time as a neonatologist. ---------------------------------------------------------------------- References: Maisel, B.A., Adeniyi-Jones, S.C., Selvage, E. et al. Abstinence scoring algorithms for treatment of neonatal opioid withdrawal syndrome (NOWS). J Perinatol 44, 1132–1136 (2024). https://doi.org/10.1038/s41372-024-01895-6
Grossman MR, Berkwitt AK, Osborn RR, Xu Y, Esserman DA, Shapiro ED, Bizzarro MJ. An Initiative to Improve the Quality of Care of Infants With Neonatal Abstinence Syndrome. Pediatrics. 2017 Jun;139(6):e20163360. doi: 10.1542/peds.2016-3360. Epub 2017 May 18. PMID: 28562267; PMCID: PMC5470506.
Patrick SW, Barfield WD, Poindexter BB; COMMITTEE ON FETUS AND NEWBORN, COMMITTEE ON SUBSTANCE USE AND PREVENTION. Neonatal Opioid Withdrawal Syndrome. Pediatrics. 2020 Nov;146(5):e2020029074. doi: 10.1542/peds.2020-029074. PMID: 33106341.
MacMillan KDL, Rendon CP, Verma K, Riblet N, Washer DB, Volpe Holmes A. Association of Rooming-in With Outcomes for Neonatal Abstinence Syndrome: A Systematic Review and Meta-analysis. JAMA Pediatr. 2018 Apr 1;172(4):345-351. doi: 10.1001/jamapediatrics.2017.5195. PMID: 29404599; PMCID: PMC5875350.
Hahn PD, Graham DA, Ozonoff A, Milliren CE. Neonatal Opioid Withdrawal Syndrome Treatment Guidelines and Birth Hospital Utilization. Pediatrics. 2024 Jul 1;154(1):e2023063635. doi: 10.1542/peds.2023-063635. PMID: 38899388.
Cheng FY, Beagan RA, Grossman MR. Neonatal Opioid Withdrawal Syndrome. Pediatr Clin North Am. 2025 Aug;72(4):639-659. doi: 10.1016/j.pcl.2025.03.006. Epub 2025 May 12. PMID: 40619192.
---------------------------------------------------------------------------- ***TIMESTAMPS*** 01:20 When to treat a baby 09:36 Non-pharmacological care for NOWS 15:16 Medical management ---------------------------------------------------------------------------- *Disclaimer*: This video is intended for educational purposes only and while we strive to give the most accurate information, errors may occur. Subsequently, this video should not be a replacement for medical advice.
AI Generated·May contain errors
Taking care of babies withdrawing from opioids
has really changed in the last decade.
We've gone from mostly treating these babies with medication,
so pharmacological methods,
to really emphasizing non-pharmacological methods,
or just giving them a lot of comfort and support
to get them through this very difficult stage of withdrawal.
I'm sure for some of the bedside nurses watching this
that have literally had to cuddle and console babies
all night long,
some of you kind of missed the medications a bit.
But as we'll discuss,
the data is really pretty convincing
about how much better
the non-pharmacological treatment is for the babies.
If you haven't already watched the last video
on what is NOWS, or neonatal opioid withdrawal syndrome,
then go back and watch that.
In this video, we're going to be talking about
the management of NOWS.
So one, how do we decide whether to treat a baby?
Two, non-pharmacological methods of treatment.
And three, pharmacological methods of management.
Hello, I'm Dr. Tala,
and I've been a neonatologist for 17 years now.
And like I said in the last video,
we were asked to cover this topic by our members.
So if you're interested in that sort of power,
then please think about joining our feeder grower community.
Right, let's start.
One, when to treat a baby.
As we talked about in the last video,
a large part of actually managing NOWS
is figuring out whether the baby
is actually withdrawing or not.
We're not just going to start giving medication
or even non-pharmacological management
to every single baby
whose mother had a positive urine drug screen,
or even if the baby had a urine drug screen.
They may not actually be withdrawing from those drugs.
And the way we decide
which babies we should be treating or not
is by scoring the babies.
And we score the babies based on
how frequent their symptoms of withdrawal are
and how severe their symptoms of withdrawal are.
And the higher the score,
the more likely that the baby needs closer management
or even medications.
The most commonly used tool in the US
is a modification of the Finnegan score.
And the Finnegan score was developed in 1970 by Dr. Finnegan.
And this score includes 21 different elements.
So really pretty time-consuming to be at the bedside
and to go through every single one of these.
And you can see all the different attributes
of the score here.
So depending on what the baby's doing
and for how long and how bad it is,
they'll get a higher score.
For example, if there is a high-pitched cry
for less than five minutes,
then the baby gets two points.
If there's an excessive high-pitched cry
for above five minutes,
then the baby's going to get three points.
If the baby sleeps for less than one hour after a feeding,
then the baby gets three points for that.
Baby will also get other points for increased tremors
and a hyperactive moroe and excoriations
and yawning several times in a row
and sneezing several times in a row.
So basically all these points are added up
to give the baby a final score.
Another variation of this score is the MOTHER score,
which stands for Maternal Opioid Treatment
Human Experimental Research,
which is a 19-point score,
pretty similar to the modified Finnegan.
But this was the score that was used
in the study of trying out morphine versus buprenorphine,
which is Subutex in that study.
Again, depending on how the baby is behaving,
you're going to get higher points for that.
So kind of the same thing,
excessive yawning and less sleep
and more irritability.
And again, you tally up the scores.
As you can see, these are pretty labor intensive
and you're doing them pretty much every three hours.
In the MOTHER scoring system,
if you got scores between nine to 12 consistently,
or you got one score above 13,
then that baby would be started on medications.
More recently, and this has been pretty fantastic,
a different scoring tool has been used increasingly
to determine whether you should be treating
for NALS or not.
And that is called the ESC,
or the Eat, Sleep, and Console scoring tool.
So the scores with this one are E,
can the baby eat more than an ounce of breast milk or formula
or can the baby breastfeed well?
Sleep, can the baby sleep for at least an hour
between feeds?
And Console, can the baby be consoled within 10 minutes?
That's it, that's what you're testing for
on all these babies.
No more 21 point Finnegan score or whatever.
And if the answer is no to any of these,
so the baby isn't eating or the baby isn't sleeping
or the baby can't be consoled,
then the team needs to readdress
the non-pharmacological management.
And if that's kind of maxed out,
then at that point, the team decides
that it's time to give medical management to the baby.
There has been lots and lots of encouraging data
on the ESC approach.
A recent study in the New England Journal of Medicine
showed that by using the ESC approach,
it can reduce the number of days
that a baby spends in hospital from 15 to eight.
So a significant difference in hospital stays.
Also the babies that were under the ESC approach
were obviously given significantly less
amounts of the opioids themselves.
Obviously it's important that whatever hospital
or institution that you're in,
everybody is doing the same thing.
They're using the same score.
There's a protocol in place for what happens
if a baby isn't doing that.
Are you still gonna give PRN medications?
Are you going to do other things non-pharmacologically?
Or are you gonna start a medication and then wean it down?
So there are still decisions to be made
even if you are using the ESC approach.
So how long should we be observing
and scoring these babies for?
So like we said already, after a baby is born
and we're worried about them actually withdrawing,
we have to watch them for a certain period of time
in the hospital.
And when we say watch them, really we're scoring them.
So whether it's the ESC score
or the modified Finnegan or mothers,
this is the way that we are objectively
observing these babies.
And we discussed in the first video
that the length of time that we watch these babies for
is going to depend on which drug the mother was on.
If she was on a drug with a long half-life like methadone,
then these babies need to be observed a lot longer
until we're absolutely certain
that they've gotten over the hump
of actually going into a withdrawal.
The AAP clinical report on NOWS
recommends that we observe babies
that were exposed to immediate release opioids
for three days,
for intermediate release opioids for four to seven days,
and for long acting opioids like methadone
for five to seven days.
The next question is where should these babies be observed?
So in the US at least,
a mother will stay in hospital after she delivers a baby
somewhere between 24 hours and four days,
depending on whether it was a vaginal delivery
or if it was a C-section.
So if that mother was on methadone
and that baby needs to stay five to seven days,
then we need to figure out
how ideally we can keep the mother with the baby
even if the mother has been discharged home.
These mothers also need to know
that babies do have to stay for observation.
And I'm sure you've all had lots of mothers
who have been very angry that they didn't know
that these babies do need to be observed
for withdrawal after delivery.
If the babies are staying with the mothers
and they begin to look like they are actively withdrawing
and they may end up needing medications,
then at that point we really should be admitting them
to the neonatal intensive care unit
so that we can observe them more carefully
and see whether they are going to need medications or not.
We don't give medications to babies
when they are not in the neonatal intensive care unit.
We don't give opioid medications to babies.
But this is where the huge problem arises.
The NICU, if you think about it,
is a horrible place to put a baby that's withdrawing.
For starters, you're most likely separating the baby
from the mother.
So you're already affecting the bonding
and affecting all the non-pharmacological care
that the mother is able to give the baby.
That in itself can make withdrawal worse.
But on top of that, think about the NICU environment.
It's loud, it's bright, it's very overstimulating.
So again, that is really not good for babies
that may be withdrawing.
Really a rooming in situation,
so where the baby is on the kind of the NICU care,
but a private room or a private area
where the mother is able to stay with the baby
is really the ideal scenario.
So the baby is getting all the bonding
and the non-pharmacological care from the mother,
but also it's not in that kind
of overly stimulating environment.
And studies have shown that when there are rooming in rooms
for babies with NAOs,
generally the babies have a shorter hospital stay
and have less need for pharmacotherapy.
Two, now let's cover non-pharmacological care
of babies with NAOs.
And as I've been alluding to,
there is increasing amounts of research
emphasizing the importance of non-pharmacological care
in babies that may be withdrawing.
In November, 2020, the AAP
or the American Academy of Pediatrics
published their recommendations
on what should be done for babies with NAOs.
And again, they really emphasized
all the non-pharmacological aspects first
and really lean into those as much as possible
before medication is started.
A study was published in Pediatrics in 2024,
which compared basically how babies did
before this policy statement came out
and after the policy statement came out.
And as would be expected after the policy statement,
fewer babies ended up needing pharmacotherapy.
So 50% in the later group versus 59% in the earlier group.
So it does cut down on opioid exposure to these babies,
this non-pharmacological emphasis.
So where does this non-pharmacological care start?
Well, from right after delivery for the mother.
These babies can be really, really tough.
They can cry.
They have a like very piercing high-pitched cry.
They are just very irritable.
They don't sleep well.
They don't eat well.
It's very, very difficult patient population
to take care of.
So these mothers who are probably already grappling
with guilt and anxiety are now having to deal
with this very difficult baby.
So you can imagine how much support
mommies need to get through this.
So really the first aspect of non-pharmacological care
is to give mothers the support that they need,
which means that we are treating them with kindness
and in a non-judgmental way, whatever they ended up taking,
that we literally help them out with feeding the baby,
that they get the lactation support
and any other nursing support that they need.
The mothers need this and the babies need this.
Now let's cover the different aspects
of non-pharmacological care for the babies.
And probably the best studied one is breastfeeding.
This has also actually kind of changed quite a bit
that we all used to be a little bit worried
about the amounts of drugs that were in the breast milk
and the baby was getting it.
Now, really, if it is a legal drug
and or the mother is on methadone or buprenorphine,
which the vast majority of the time it is given legally,
then we do allow the mothers to breastfeed these babies.
Often this really low dose of the drug
that the mother is probably still on,
getting through to the babies through the breast milk
is often enough to like stop
or to control the symptoms of withdrawal in the babies.
But again, you can imagine how difficult
it is breastfeeding these babies.
They are angry, they are irritable, they are poor feeders.
So again, it's going to be really important
to support mothers with good lactation specialists
and to keep encouraging mothers
to work on the breastfeeding.
Going beyond breastfeeding, like we said,
a really important part of non-pharmacological care
is keeping the mother-infant dyad together.
So a place where the mother can hold the baby,
they can do skin-to-skin
and family members can continue to console
and take care of the baby.
And like we talked about,
the actual environment that the babies are in,
we want it to be a quiet, non-stimulating, non-bustled,
just very calm environment
that hopefully the mother can stay in with the baby.
As we all know, unfortunately,
sometimes this isn't the case.
Sometimes the mother leaves as soon as she delivers the baby.
Sometimes the mother knows
that the baby is not going to end up going home with her
because of legal reasons.
And so she has no interest in bonding with the baby at all.
In these scenarios, obviously the ideal thing
is to get a very invested family member
that will kind of take on that role of the mother
and be there to support this baby through this.
In some units, there are also volunteer cuddlers
that can sometimes give the babies they love they need.
But in the cases where the mothers aren't there,
unfortunately, a lot of this non-pharmacological care
does fall onto the nurses, and it's not easy.
And so obviously there needs to be some sort of system
to make sure that the nurses
aren't getting burnt out as well
in taking care of these very difficult little babies.
And for the providers in the NICU,
we really should be interrupting these babies' sleep
or just when they're quiet, as little as possible.
So we should ideally be trying to cluster cares
with the nurses when they're feeding them
or changing the diaper or whatever,
just so that we could try to enable them
to have as much peace as possible.
Really, that's true of all babies,
but as I know you all know, that isn't always possible.
The last thing that I'll say about non-pharmacological care
is that the AAP really emphasizing
in tailoring the non-pharmacological care
depending on what's really triggering the baby.
So if the baby really can't handle bright lights at all,
then make sure the lights are always dimmed.
If the baby is really having a lot of tremors
and is hypertonic,
then make sure that the baby is being swaddled.
A lot of babies like those little swing things
that really relaxes them.
And so ideally we would have all these toys
in the ideal environment set up
to try to soothe these babies as much as possible.
Three, medical management.
So let's say that you have been giving
the absolute ideal non-pharmacological therapy.
You're keeping the baby in a nice soothing environment.
The baby's being breastfed and held and loved.
And even with that,
the baby's symptoms are extremely severe
or the baby is losing weight
because it's eating so little and the stools are so loose.
Or the baby's got such a horrible diaper rash
because of the loose stools
and the baby has like failure to thrive.
At some point, we do end up needing
to treat these babies medically.
The way that we used to give pharmacological therapy
was that if the baby's scores were high enough,
then we would actually start the baby
on a consistent medication.
A lot of units ended up using morphine
and we would give that drug
and escalate it or titrate it
depending on the baby's symptoms.
And babies would often end up on these drugs
for days or weeks, sometimes even months,
just kind of slowly going up and down.
And as another quick aside,
this was also something really bad
about the Finnegan scoring.
If the baby was like a month old
and the baby was just awake more
or would just get agitated more
because it did want the stimulation
that a regular one month old would want,
then they would score higher.
So the Finnegan scoring was really not ideal
as babies got a lot older.
Now though, all of that has changed
because if your unit is using the ESC scoring tool,
then we are in a position
where we can still just give one dose of morphine PRN.
So if the baby in the last three hours
hadn't slept at all
or hasn't been able to be consoled within 10 minutes,
then we can give them one dose of morphine.
We're not committing to give it to them
like around the clock
for like the next few days or whatever.
In treating NALS,
because the baby was exposed to an opioid,
then we should be treating with an opioid.
And probably the most commonly used drug
in the US at least is morphine.
Previous studies have been done
with using methadone or buprenorphine,
which is the subutex,
which are both longer acting
or have a longer half-life than the morphine.
And various studies have shown
that maybe using methadone or subutex
actually does decrease the days of hospital stay.
But a lot of these studies were done
in with the like Finnegan scoring
rather than with the new ESC scoring,
especially if you are in a unit
that is just giving those doses PRN.
So for example,
if the baby is withdrawing or whatever,
you just give that one.
You're not committing to be going up and down
and titrating a drug.
So even if a baby is following the ESC scoring
and is consistently having these symptoms,
so for example,
whatever dose of morphine that you may be giving PRN,
maybe it's 0.03 mg per kg or 0.04 mg per kg.
And you're basically consistently
having to give this every four hours or so.
At some point,
you're probably going to want to put the baby
on a maintenance dose
and just keep that going around the clock
trying to control the symptoms.
Sometimes you have to escalate the dose
because even on your initial starting dose in your unit,
whatever that may be,
you are still not controlling the symptoms of the baby.
So you carry on marching up on your dose
and eventually at some point,
if the baby's still having symptoms
on a higher morphine dose,
whatever dose your unit decides,
whether it's 0.1 mg per kg,
then sometimes the baby needs additional medications
to try to help control it
because you don't really want to go any higher
on the morphine
and make the baby completely sleepy
and lethargic from the morphine itself.
In these cases,
some secondary medications are used like Clonidine,
which is an alpha-2 adrenergic agonist.
And this kind of like works synergistically with a morphine
and can really help that last little bit
of withdrawal control that we need.
Phenobarbital has also been used classically
as a secondary medication in withdrawal.
Again, do not use these as primary medications.
They are not opioids.
So you may be feeling a little bit better
because the baby is more sleepy,
but the baby's symptoms aren't truly controlled.
And once you started treatment
or once you are observing the baby in the hospital,
how long does the baby have to stay there?
Well, we, as of now,
do not send babies home on any of these medications.
And so generally,
we want the babies off the medications
for at least 24 to 48 hours
to make sure that the baby
isn't having any withdrawal symptoms.
And we also need to make sure
that the baby is eating well, is gaining weight,
and the mother or whoever is taking care
of this baby at home
is capable of doing all these cares for the babies.
It's one thing if you have the best primary nurse
on the planet that's been able to take care
of this baby and feed the baby,
but then the mother is completely incapable
of actually dealing with this little,
very angry baby that doesn't eat very well.
So it's very important to set up
a as good as possible home environment
before these babies go home.
Okay, that was it.
What do you all do in your unit?
Are you using the ESC guidelines?
Do you love it?
I'm sure if you're a bedside nurse,
then you've got a few things to say about it as well.
But overall, we do know that it does decrease
the amount of pharmacotherapy
that these babies are exposed to,
and it decreases the length of hospital stay.
I hope that you enjoyed that.
And again, I want to thank you all for being here.